1Rodriguez G C, Haisley C, Hurteau J, et al. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol Oncol, 2001,80(2) :245-253.
2Gottseh M L, Van Kirk E A, Murdoeh W J. Turnout necrosis factor alpha up-regulates matrix metalloproteinase-2 activity in periovulatory ovine follicle: metamorphic and endocrine implications. Reprod Fertil Dev, 2000,12(1-2) :75-80.
3Pitze L, Ludemann S, Wuttke W. Secretion and gene expression of metalloproteinases and gene expression of their inhibitors in porcine corpora lutea at different stage of the luteal phase. Biol Reprod,2000,62(5) :1121 -1127.
4Bernhard E J, Gruber S B, Muschel R J. Direct evidence linking expression of matrix metalloproteinases 9 (92 000 gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo ceils. Proc Nail Acad Sci U S A, 1994, 91:4293-4297.
5Kaneanoto T, Reich R, Royce L, et al. Identification of amino acid sequence from the laminin A chain that stimulates metastasis and collagense IV production. Proc Natl Acad Sci U S A, 1990,87:2279-2283.
6Byers L Y, Oshorne J L, Carson L F, et al. Incraesed levels of laminin in ascitic fluid of patients with ovarian cancer. Cancer Lett, 1995,88: 67-72.
7Campo E, Merino M J, Tavassoli F A, et al. Evaluation of basement membrane components and the 72 000 type IV collagenase in serous tumors of the ovary. Am J Surg Pathol, 1992,16(5) :500-5O7.
8Sakata K, Shigemasa K, Nagai N, et el. Expression of matrix metalloproteinases (MMP-2,MMP-9, MT1-MMP ) and their inhibitors(TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Int J Oncol, 2000,17(4) :673-681.
9Kikkawa F, Tamakoshi K, Nawa A, et al. Positive corrolation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues. Cancer Lett,1997,120(1) : 109- 115.
10Takeanura M, Azuma C, Kimura T, et al. Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues. Int J Gynaecol Obstet, 1994,46(3) :303-309.
